Literature DB >> 21517990

Withholding and withdrawing renal support in acute kidney injury.

Rolando Claure-Del Granado1, Ravindra L Mehta.   

Abstract

Management of critically ill patients with acute kidney injury (AKI) is mainly limited to supportive therapy, with dialysis as one of the main components. Whether or not to offer dialysis and when to withdraw dialysis is a one of the many choices physicians face in daily clinical practice. Withholding or withdrawing renal replacement therapy is a complex decision and depends on many interacting factors, which are unique for each patient and their families and for the care team. An evidence-based guideline with nine specific recommendations for managing patients has been available however is infrequently employed to help clinical decision making. In this review, we discuss the important issues affecting decisions to withhold or withdraw dialysis in AKI patients and provide an approach for making these decisions for patient management.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21517990     DOI: 10.1111/j.1525-139X.2011.00832.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  4 in total

1.  Guiding Physician Decisions for Initiating Dialysis for AKI: Is Progress on the Horizon?

Authors:  Etienne Macedo; Ravindra L Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2017-01-24       Impact factor: 8.237

2.  Patients with Hepatorenal Syndrome Should Be Dialyzed? COMMENTARY.

Authors:  Kevin R Regner
Journal:  Kidney360       Date:  2020-12-16

3.  Impact of weaning from acute dialytic therapy on outcomes of chronic kidney disease following urgent-start dialysis.

Authors:  Yung-Ming Chen; Wen-Yi Li; Vin-Cent Wu; Yi-Cheng Wang; Shang-Jyh Hwang; Shih-Hwa Lin; Kwan-Dun Wu
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 4.  Palliative Care for Patients with Kidney Disease.

Authors:  Iacopo Lanini; Sara Samoni; Faeq Husain-Syed; Sergio Fabbri; Filippo Canzani; Andrea Messeri; Rocco Domenico Mediati; Zaccaria Ricci; Stefano Romagnoli; Gianluca Villa
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.